Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Response”

630 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 630 results

Not applicableStudy completedNCT03697928
What this trial is testing

Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability

Who this might be right for
Metabolism and Nutrition DisorderMetabolic Disturbance
Maastricht University 13
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Not applicableStudy completedNCT00109525
What this trial is testing

Early Diagnosis of Candidiasis in Premature Infants

Who this might be right for
InfectionCandidaCandidiasis+4 more
NICHD Neonatal Research Network 1,500
Not applicableEnded earlyNCT01722890
What this trial is testing

CharactHer. ICORG 12-09, V3

Who this might be right for
HER2-positive Breast CancerTNM Stage II-IV Breast Cancer
Cancer Trials Ireland 130
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT01850004
What this trial is testing

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 84
Large-scale testing (Phase 3)Study completedNCT01132638
What this trial is testing

Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease

Who this might be right for
GERD
Takeda 713
Large-scale testing (Phase 3)Ended earlyNCT01095445
What this trial is testing

EXtended Therapy in Hepatitis C Genotype 3 Infected Patients

Who this might be right for
Chronic Hepatitis C
University Health Network, Toronto 2
Testing effectiveness (Phase 2)Study completedNCT00363649
What this trial is testing

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Testing effectiveness (Phase 2)UnknownNCT01566799
What this trial is testing

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Instituto Nacional de Cancerologia de Mexico 60
Testing effectiveness (Phase 2)Study completedNCT02458014
What this trial is testing

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

Who this might be right for
Adult Acute Lymphoblastic Leukemia in Complete RemissionB Acute Lymphoblastic LeukemiaMinimal Residual Disease+1 more
M.D. Anderson Cancer Center 36
Not applicableStudy completedNCT06149390
What this trial is testing

ASCT Versus Chemotherapy as First-Line Consolidation Therapy inT-Cell Lymphoma

Who this might be right for
T-cell Lymphoma Adults
Huazhong University of Science and Technology 347
Early research (Phase 1)Study completedNCT01842139
What this trial is testing

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more
University of Chicago 7
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Large-scale testing (Phase 3)Looking for participantsNCT06312137
What this trial is testing

Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Who this might be right for
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC 780
Not applicableStudy completedNCT04271657
What this trial is testing

RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Early research (Phase 1)Study completedNCT00233961
What this trial is testing

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

Who this might be right for
Leukemia
Herbert Irving Comprehensive Cancer Center 20
Very early researchEnded earlyNCT02966730
What this trial is testing

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Who this might be right for
Follicular LymphomaFollicular Lymphoma, Grade 1Follicular Lymphoma, Grade 2+1 more
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00250042
What this trial is testing

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Who this might be right for
Leukemia, OtherCancer
New Mexico Cancer Research Alliance 6
Load More Results